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 Today, numerous laboratory procedures are available 
for measurement of clinically relevant biomarkers. Evi-
dence-based practice guidelines are considered of valu-
able assistance in medical decision-making, however, 
recommending uniform cut-offs is only meaningful pro-
vided different measurement procedures give equivalent 
results within clinically relevant constraints. To achieve 
this, trueness-based standardization is the ideal scenario. 
For a documentation of the efforts already achieved in 
this regard, we refer to the International System of Units 
(SI)-traceable reference materials and measurement pro-
cedures in the database of the Joint Committee for Trace-
ability in Laboratory Medicine (http://www.bipm.org/
jctlm). These apply for well-defined chemical entities 
or internationally recognized reference method-defined 
measurands, such as enzymes. For the more complicated 
components, particularly those present in the biological 
system as mixture, it is unlikely that the goal of SI-trace-
ability will be accomplished in the short-term [ 1 ]. This 
was exactly the incentive to reflect on the utility of estab-
lishing a technical infrastructure based on other means 
than reference measurement procedures to accomplish 
harmonization with equivalency of measurement results 
[ 2 ,  3 ]. From a scrutiny of literature we were surprised to 
find that, already decades ago, the potential of the com-
bination of split-sample multiple method comparison 
studies with statistical analysis of the data by principal 
component analysis (PCA) had been described [ 4 – 6 ]. 
These exemplary studies showed that PCA can compare 
differences and similarities between measurement pro-
cedures, provide a so-called composite reference value 
for each of the measured samples, so that they subse-
quently can be used as a valid basis for calibration and 
accomplishment of equivalent measurement results. 
This approach eliminates calibration biases among dif-
ferent measurement procedures, but does not establish a 
link to the truth. To rehearse this alternative to harmoni-
zation of measurements, we did a proof of concept study. 
We applied PCA to existing data from a split-sample 
method comparison study between immunoassays and 
an isotope dilution-mass spectrometry (ID-MS)-based 
candidate SI-traceable reference measurement proce-
dure for serum or plasma insulin [ 7 ,  8 ]. The data set was 
of particular interest because it had been used before 
to prove the feasibility of SI-based standardization of 
insulin measurements. 
 The data were measurement results for 36 single-
donor sera obtained by 11 immunoassays from nine manu-
facturers and ID-MS. The sera covered an insulin con-
centration range from 18 to 779 pmol/L (3.1 to 130 mU/L, 
according to the conversion factor 0.1667 adopted from 
http://diabetes.diabetesjournals.org/site/misc/SIunits.
pdf). The uncertainty of the serum concentrations meas-
ured by ID-MS was approximately 4%. We applied PCA to 
derive the all-procedure trimmed mean (APTM) from the 
immunoassay results. For a detailed account of PCA, we 
refer to reference [ 9 ]. The assumption at the basis of the 
used PCA model was that the 11 immunoassays are dif-
ferent procedures that measure a given quantity with an 
unknown underlying reference value in the samples, and 
that the measured quantity values include a random and 
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systematic error component. Note that the systematic 
error or bias may consist of a fixed, method-specific part 
which expresses to what extent a procedure consistently 
over/underestimates the reference value, and a random, 
sample-specific part which is due to non-specificity, i.e., 
response to other substances than the target. With  x ij the 
measurement of the  j th procedure for the  i th sample, 
the PCA model can be written as  x ij = α j + β j  f i + ε ij , where the 
values  f i  are the reference values for the samples. Note 
that in the absence of a reference measurement pro-
cedure the parameters  β j and reference values  f i in the 
above model can only be estimated relatively, i.e., up 
to an unknown scalar. We used a robust PCA procedure 
[ 10 ]. Note that the standard choice in PCA algorithms is 
to return estimates of the reference values  f i that are cen-
tered around zero. However, for our purposes these rela-
tive estimates can easily be adjusted to better match the 
centers of the results. We compared the APTM from PCA 
with the ID-MS results in a scatter plot and a percent-
age residual plot using weighted least squares regres-
sion analysis. We also did correlation analysis between 
the measurement results by the 11 immunoassays and 
the ID-MS results and APTM, respectively. For data 
analysis, we used Microsoft Excel  ®  , except for weighted 
least squares regression analysis, for which we utilized 
CB-Stat. 
 Figure 1 compares the insulin concentrations of 
the panel samples calculated as APTM from PCA (con-
centrations in pmol/L) with those measured by ID-MS 
in a scatter diagram (A) and a percentage residual plot 
(B). The weighted least squares regression and cor-
relation data were APTM = 1.089 × ID-MS+4.31 pmol/L 
and r 2 = 0.9970, with 95% of the percentage residuals 
within  ± 6.7%. Correlation analysis of the measurement 
results by the 11 immunoassays with ID-MS and the 
APTM gave a mean Pearson correlation coefficient r 2 
of 0.9916 (range 0.9639 – 0.9992) and 0.9929 (0.9710 –
 0.9994), respectively. 
 The data set from the insulin method comparison 
and standardization with an SI-traceable reference meas-
urement procedure served as proof of concept for the 
use of the APTM from PCA as alternative to calibration. 
It allowed in particular the comparison of the quality of 
both calibration approaches. The validity of the statistical 
approach can be inferred from the excellent correlation 
of the APTM with ID-MS (r 2 = 0.9970). Moreover, the obser-
vation that 95% of the percentage residuals are within 
limits that correspond fairly well with the expected dis-
tribution assuming that the uncertainty for PCA is the 
same as for ID-MS values ( √ 2*4% = 5.7%) reflects that the 
APTM compensates well for the among-assay differences 
in specificity. This is an important aspect of the proof 
of concept, in view of the fact that sufficient specific-
ity is inherent to the reference measurement procedure 
approach. The success of calibration against the APTM 
relies on the fact that the concerned immunoassays are 
in a mature status [see the high values for r 2 ( > 0.99) in the 
correlation analysis between the immunoassay results 
and the APTM]. It should be noted that the regression 
data (APTM vs. ID-MS) show a positive bias of the APTM 
vs. the reference measurement procedure, reflecting that 
only the latter establishes SI-traceability, vs. the APTM 
that is a statistical composite of the calibration status of 
the immunoassays it is based on. Therefore, it is impor-
tant to consider that the continuity of calibration against 
the APTM must be ensured by overlapping measure-
ments of the first calibration panel with the follow-up 
ones [ 2 ]. The panels may serve as predicate panels for 
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 Figure 1   Comparison of insulin concentrations of the panel samples calculated as APTM from PCA (pmol/L), with those measured by ID-MS. 
(A) Scatter diagram (with dotted line: line of equality) and (B) percentage residual plot (with dotted lines: 1.96 * SD % residuals ). 
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all measurement procedures that are entering the market 
after the first calibration. 
 In conclusion, we reiterated the great potential of the 
APTM derived by PCA to contribute to the harmonization 
of laboratory measurement procedures. Our study con-
firmed not only the validity of this statistical approach, 
but also showed that it results in an equivalent quality 
of calibration as the reference measurement procedure 
approach. Naturally, the more mature measurement pro-
cedures contribute to the APTM, the better the harmoni-
zation will be. Nevertheless, even when a first method 
comparison shows that harmonization is not yet feasible 
(gross differences between the results), it can be helpful 
for manufacturers towards the improvement of quality, 
so that harmonization may become feasible in a later 
stage. 
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